SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Turn Therapeutics announced publication of a peer-reviewed study in the Journal of Dermatological Treatment demonstrating GX-03's efficacy in an IL-36...
Raymond James Financial Inc. hosted its 2026 Analyst & Investor Day on May 27, 2026, with presentations on strategic overview, capital markets, techno...
Ryerson Holding Corporation presented materials at the KeyBanc Industrials and Basic Materials Conference in May 2026. The filing includes forward-loo...
Cheniere Energy Partners, L.P. agreed to sell $1 billion in 5.350% senior notes due 2036 and $750 million in 6.050% senior notes due 2056 in a private...
Labcorp will present at the 2026 Jefferies Global Healthcare Conference in New York on June 3, with a live webcast available on its investor relations...
Kemper Corporation announced the appointment of Stephen J. McAnena as President and CEO, replacing interim CEO Tom Evans who will return to his role a...
Mira Pharmaceuticals submitted an exhibit filing (EX-10.1) with the SEC. The specific content and market impact cannot be determined from the limited ...
HCW Biologics exercised its option to regain exclusive ex vivo rights to HCW9206 and HCW9201 compounds from Wugen at no cost while retaining upfront f...
American Tower Corporation issued €750 million in senior notes due 2033 with a 4.000% coupon rate under a supplemental indenture. The offering represe...
Mesa Laboratories posted fourth quarter fiscal 2026 results with 2.6% revenue growth and 87% operating income increase, while reducing debt by $14.7M....
Monro reported Q4 fiscal 2026 sales decreased 7.2% to $273.8M, primarily from 145 store closures and comparable store sales decline of 2.4%, while gro...
Abercrombie & Fitch delivered record first quarter net sales of $1.1 billion with 14 consecutive quarters of growth, driven by strong Americas and APA...
TDAC, a blank check company, has entered into a merger agreement with Prologium Holding Inc. dated May 27, 2026, involving two sequential mergers that...
ZEO ScientifiX formalized a Physician-Led Patient Masterclass program following grassroots demand, building on its network of 600+ trained physicians ...
Precision BioSciences announced late-breaking clinical data from the ELIMINATE-B study demonstrating that PBGENE-HBV directly eliminated cccDNA with a...
Movado reported Q1 FY2027 net sales of $142.4M (+8% YoY) with diluted EPS of $0.30 versus $0.06 prior year, while expanding gross margins 320 basis po...
G-III Apparel Group's Board of Directors declared a quarterly cash dividend of $0.10 per share, payable July 8, 2026 to stockholders of record on June...
Bath & Body Works reported first quarter net sales of $1.4 billion, down 3% year-over-year, but exceeded earnings guidance with adjusted EPS of $0.32....
Tonix announced publication of Phase 1 clinical data for TNX-1500 in the Journal of Clinical Immunology, showing the drug was well-tolerated with favo...
The closed-end investment company reported a GAAP net loss of $74.7 million ($3.63 per share) for Q4 ended March 31, 2026, driven by $77.6 million in ...